Home » Topics » BioWorld Science, Dermatologic

BioWorld Science, Dermatologic
RSS

OncorPharm acquires rights to dithymidine-based products

July 12, 1996

ProCyte seeks FDA marketing clearance for OsmoCyte

July 12, 1996

FDA issues nonapprovable letter for Avita; development elsewhere on track

July 5, 1996

ProCyte launches Iamin gel in U.S.

July 5, 1996

ICN's Viquin Forte launched in U.S.

June 28, 1996

Connective Therapeutics to develop new formulation of betamethasone valerate

June 28, 1996

Collagen Corporation and Biomatrix enter marketing agreement

June 21, 1996

KCB-1 skin ulcer clinical trials completed

June 21, 1996

Positive phase III results for new Solarase formulation

June 21, 1996

5alpha-reductase type 1 inhibitors from Merck & Co.

June 21, 1996

Popular Stories

Today's news in brief
BioWorld
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke
BioWorld Science
Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...
New mechanism of action identified for QC-6352
BioWorld Science
QC-6352 is a small molecule developed to inhibit the histone demethylase 4 (KDM4) that has shown potent antitumoral activity and which has a derivative named...
VST Bio’s VB-001 is neuroprotector after stroke
BioWorld Science
At the recent International Stroke Conference, researchers from VST Bio Corp. and Yale University presented preclinical data regarding VB-001, a monoclonal...